Last Updated : November 20, 2019
Today, CADTH has issued recommendations for:
cyclosporine (Verkazia)
Indications : Severe vernal keratoconjunctivitis, pediatric (≥4 years)
Recommendation : Reimburse with clinical criteria and/or conditions
Last Updated : November 20, 2019